A serial, cross-sectional study has found that gabapentinoid medication use among adults with cancer in the United States has more than doubled over a recent 10-year period.
FEBRUARY 14, 2020
FEBRUARY 14, 2020
A serial, cross-sectional study has found that gabapentinoid medication use among adults with cancer in the United States has more than doubled over a recent 10-year period.